Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Revenue

Rigel Pharmaceuticals had revenue of $55.31M in the quarter ending September 30, 2024, with 96.58% growth. This brings the company's revenue in the last twelve months to $157.37M, up 21.65% year-over-year. In the year 2023, Rigel Pharmaceuticals had annual revenue of $115.78M with 0.03% growth.

• Revenue (ttm): $157.37M
• Revenue Growth: +21.65%
• P/S Ratio: 1.90
• Revenue / Employee: $1,070,571
• Employees: 147
• Market Cap: 301.04M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	115.78M	40.00K	0.03%
Dec 31, 2022	115.74M	-22.99M	-16.57%
Dec 31, 2021	138.74M	30.12M	27.72%
Dec 31, 2020	108.62M	49.33M	83.21%
Dec 31, 2019	59.29M	14.78M	33.20%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.